Aesthet Surg J
August 2019
Background: Excessive sweating is a clinical condition that can be improved with type-A botulinum toxin (BTX-A).
Objectives: To evaluate and compare the largest diameter of sweating inhibition halo (SIH) of 5 different commercially available BTX-A, in five different doses, in a 6-month-long clinical evaluation.
Methods: Twenty-five adult female volunteers were injected in the dorsal trunk area with both 100 units (100UI) and 500 units (500UI) BTX-A products, reconstituted in a ratio of 1:2.
Clin Cosmet Investig Dermatol
July 2015
Background: Skin aging is a natural process that may be aggravated by environmental factors. Topical products are the conventional means to combat aging; however, the use of oral supplements is on the rise to assist in the management of aged skin.
Objective: The purpose of this study was to assess the effects and safety of an oral supplement containing (per tablet) marine protein (105 mg), vitamin C (27 mg), grape seed extract (13.
Dermatol Online J
November 2012
Background: Diffusion halo profiles of different commercially available type-A botulinum toxins (BTX-A) have been studied.
Objective: To evaluate and compare the largest diameter of diffusion halos of 5 different doses of 5 different commercially available BTX-A.
Methods: Twenty-five adult female volunteers were included.